{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T17:46:15Z","timestamp":1773423975130,"version":"3.50.1"},"publisher-location":"Cham","reference-count":186,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030105600","type":"print"},{"value":"9783030105617","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/164_2018_177","type":"book-chapter","created":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T10:34:24Z","timestamp":1543228464000},"page":"69-110","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Self-Experiments with Psychoactive Substances: A Historical Perspective"],"prefix":"10.1007","author":[{"given":"Torsten","family":"Passie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon D.","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,27]]},"reference":[{"key":"177_CR1","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s13181-018-0659-3","volume":"14","author":"R Abouchedid","year":"2018","unstructured":"Abouchedid R, Gilks T, Dargan PI, Archer JRH, Wood DM (2018) Assessment of the availability, cost, and motivations for use over time of the new psychoactive substances-benzodiazepines diclazepam, flubromazepam, and pyrazolam-in the UK. J Med Toxicol 14:134\u2013143","journal-title":"J Med Toxicol"},{"key":"177_CR2","volume-title":"The use of LSD in psychotherapy and alcoholism","year":"1967","unstructured":"Abramson HA (ed) (1967) The use of LSD in psychotherapy and alcoholism. Bobbs-Merrill, Indianapolis"},{"key":"177_CR3","unstructured":"Alberts L (1921) Einwirkungen des Meskalins auf komplizierte psychische Vorg\u00e4nge. Dissertation, Heidelberg University, Heidelberg"},{"key":"177_CR4","first-page":"238","volume-title":"A pharmacologic approach to the study of the mind","author":"G Alles","year":"1959","unstructured":"Alles G (1959) Subjective reactions to phenethylamine hallucinogens. In: Featherstone RM, Simon A (eds) A pharmacologic approach to the study of the mind. C.C. Thomas, Springfield, pp 238\u2013250"},{"key":"177_CR5","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1056\/NEJM197202172860704","volume":"286","author":"LK Altman","year":"1972","unstructured":"Altman LK (1972) Auto-experimentation \u2013 an unappreciated tradition in medical science. N Eng J Med 286:346\u2013352","journal-title":"N Eng J Med"},{"key":"177_CR6","volume-title":"Who goes first? The story of self-experimentation in medicine","author":"LK Altman","year":"1986","unstructured":"Altman LK (1986) Who goes first? The story of self-experimentation in medicine. Random House, New York"},{"key":"177_CR7","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1093\/jat\/bky012","volume":"42","author":"A Ameline","year":"2018","unstructured":"Ameline A, Richeval C, Gaulier JM, Raul JS, Kintz P (2018) Characterization of flunitrazolam, a new designer benzodiazepine, in oral fluid after a controlled single administration. J Anal Toxicol 42:e58\u2013e60","journal-title":"J Anal Toxicol"},{"issue":"Supplement 1","key":"177_CR8","first-page":"47","volume":"4","author":"G Ammon","year":"1971","unstructured":"Ammon G, Patterson PGR (1971) Peyote: Zwei verschiedene Ich-Erfahrungen. Dyn Psychiatr 4(Supplement 1):47\u201371","journal-title":"Dyn Psychiatr"},{"key":"177_CR9","first-page":"8","volume-title":"QuaSAR \u2013 quantitative structure\u2013activity relationships. NIDA research monograph","author":"GM Anderson","year":"1978","unstructured":"Anderson GM, Braun G, Braun U, Nichols DE, Shulgin AT (1978) Absolute configuration and psychotomimetic activity. In: Barnett G, Trsic M, Willette R (eds) QuaSAR \u2013 quantitative structure\u2013activity relationships. NIDA research monograph, vol 22. United States Department of Health, Education, and Welfare, Washington, pp 8\u201315"},{"key":"177_CR10","first-page":"129","volume":"6","author":"OH Arnold","year":"1953","unstructured":"Arnold OH, Hoff H (1953) Untersuchungen \u00fcber die Wirkungsweise von Lysergs\u00e4uredi\u00e4thylamid. Wien Z Nervenheilkd Grenzgeb 6:129\u2013150","journal-title":"Wien Z Nervenheilkd Grenzgeb"},{"key":"177_CR11","volume-title":"Peopled darkness: perceptual transformation through Salvia divinorum","author":"JD Arthur","year":"2008","unstructured":"Arthur JD (2008) Peopled darkness: perceptual transformation through Salvia divinorum. iUniverse, New York"},{"key":"177_CR12","doi-asserted-by":"crossref","first-page":"e2610","DOI":"10.1002\/hup.2610","volume":"32","author":"S Assi","year":"2017","unstructured":"Assi S, Gulyamova N, Kneller P, Osselton D (2017) The effects and toxicity of cathinones from the users\u2019 perspectives: a qualitative study. Hum Psychopharmacol 32:e2610","journal-title":"Hum Psychopharmacol"},{"key":"177_CR13","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/jms.1558","volume":"44","author":"V Auw\u00e4rter","year":"2009","unstructured":"Auw\u00e4rter V, Dresen S, Weinmann W, Muller M, Putz M, Ferreiros N (2009) \u2018Spice\u2019 and other herbal blends: harmless incense or cannabinoid designer drugs? J Mass Spectrom 44:832\u2013837","journal-title":"J Mass Spectrom"},{"key":"177_CR14","volume-title":"The science behind the headlines","author":"MH Baumann","year":"2017","unstructured":"Baumann MH, Glennon RA, Wiley JL (2017) Neuropharmacology of new psychoactive substances (NPS). In: The science behind the headlines. Springer, Cham"},{"key":"177_CR15","first-page":"402","volume":"2","author":"AM Becker","year":"1949","unstructured":"Becker AM (1949) Zur Psychopathologie der Lysergs\u00e4uredi\u00e4thylamidwirkung. Wiener Z Nervenhk 2:402\u2013407","journal-title":"Wiener Z Nervenhk"},{"key":"177_CR16","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1001\/jama.1959.73000220003010","volume":"169","author":"HK Beecher","year":"1959","unstructured":"Beecher HK (1959) Experimentation in man. J Am Med Assoc 169:461\u2013478","journal-title":"J Am Med Assoc"},{"key":"177_CR17","unstructured":"Benz E (1989) Halluzinogen-unterst\u00fctzte Psychotherapie. Medical dissertation, University of Z\u00fcrich, Z\u00fcrich"},{"key":"177_CR18","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1111\/j.1360-0443.2010.02948.x","volume":"105","author":"U Benzenh\u00f6fer","year":"2010","unstructured":"Benzenh\u00f6fer U, Passie T (2010) Rediscovering MDMA (ecstasy): the role of the American chemist Alexander T. Shulgin. Addiction 105:1355\u20131361","journal-title":"Addiction"},{"key":"177_CR19","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/BF02896052","volume":"84","author":"K Beringer","year":"1923","unstructured":"Beringer K (1923) Experimentelle Psychosen durch Mescalin. Z ges Neurol Psychiatr 84:426\u2013433","journal-title":"Z ges Neurol Psychiatr"},{"key":"177_CR20","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-662-11451-3","volume-title":"Der Meskalinrausch","author":"K Beringer","year":"1927","unstructured":"Beringer K (1927) Der Meskalinrausch. Springer, Berlin"},{"key":"177_CR21","first-page":"337","volume":"5","author":"K Beringer","year":"1932","unstructured":"Beringer K (1932) Zur Klinik des Haschischrausches. Nervenarzt 5:337\u2013342","journal-title":"Nervenarzt"},{"key":"177_CR22","doi-asserted-by":"crossref","DOI":"10.5040\/9798400617140","volume-title":"Beatniks: a guide to an American subculture","author":"A Bisbort","year":"2009","unstructured":"Bisbort A (2009) Beatniks: a guide to an American subculture. Greenwood, Westport"},{"key":"177_CR23","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/dta.1686","volume":"6","author":"SD Brandt","year":"2014","unstructured":"Brandt SD, King LA, Evans-Brown M (2014) The new drug phenomenon. Drug Test Anal 6:587\u2013597","journal-title":"Drug Test Anal"},{"key":"177_CR24","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000219440","volume":"13","author":"O Bumke","year":"1903","unstructured":"Bumke O (1903) Scopolaminum hydrobromicum. Monatsschr Psychiatr Neurol 13:62\u201369","journal-title":"Monatsschr Psychiatr Neurol"},{"key":"177_CR25","volume-title":"LSD psychotherapy: an exploration of psychedelic and psycholytic therapy","author":"WV Caldwell","year":"1968","unstructured":"Caldwell WV (1968) LSD psychotherapy: an exploration of psychedelic and psycholytic therapy. Grove Press, New York"},{"key":"177_CR26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/schbul\/sbm047","volume":"34","author":"T Calton","year":"2008","unstructured":"Calton T, Ferriter M, Huband N, Spandler H (2008) A systematic review of the Soteria paradigm for the treatment of people diagnosed with schizophrenia. Schizophr Bull 34:181\u2013192","journal-title":"Schizophr Bull"},{"key":"177_CR27","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","volume":"3","author":"RL Carhart-Harris","year":"2016","unstructured":"Carhart-Harris RL, Bolstridge M, Rucker J, Day CM, Erritzoe D, Kaelen M, Bloomfield M, Rickard JA, Forbes B, Feilding A, Taylor D, Pilling S, Curran VH, Nutt DJ (2016) Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Lancet Psychiatry 3:619\u2013627","journal-title":"Lancet Psychiatry"},{"key":"177_CR28","volume-title":"A history of medicine","author":"A Castiglioni","year":"1947","unstructured":"Castiglioni A (1947) A history of medicine. Alfred A. Knopf, New York"},{"key":"177_CR29","first-page":"106","volume-title":"The beyond within the L.S.D. story","author":"S Cohen","year":"1964","unstructured":"Cohen S (1964) The beyond within the L.S.D. story. Atheneum, New York, pp 106\u2013111"},{"key":"177_CR30","first-page":"11","volume-title":"The use of LSD in psychotherapy","author":"S Cohen","year":"1967","unstructured":"Cohen S (1967) Discussion. In: Abramson HA (ed) The use of LSD in psychotherapy. Josiah Macy, New York, p 11"},{"key":"177_CR31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1600-0447.1949.tb04588.x","volume":"24","author":"G Condrau","year":"1949","unstructured":"Condrau G (1949) Klinische Erfahrungen an Geisteskranken mit Lysergs\u00e4ure-Di\u00e4thylamid. Acta Psychiatr Scand 24:9\u201332","journal-title":"Acta Psychiatr Scand"},{"key":"177_CR32","unstructured":"Crowley A ([1917] 1973) Cocaine. Level Press, San Francisco"},{"key":"177_CR33","volume-title":"Novel psychoactive substances","year":"2013","unstructured":"Dargan PI, Wood DM (eds) (2013) Novel psychoactive substances. Academic Press, Amsterdam"},{"key":"177_CR34","volume-title":"Researches, chemical and philosophical: chiefly concerning nitrous oxide, or diphlogisticated nitrous air, and its respiration","author":"H Davy","year":"1800","unstructured":"Davy H (1800) Researches, chemical and philosophical: chiefly concerning nitrous oxide, or diphlogisticated nitrous air, and its respiration. J. Johnson, London"},{"key":"177_CR35","first-page":"142","volume-title":"Utopiates \u2013 the use and users of LSD","author":"JJ Downing","year":"1965","unstructured":"Downing JJ (1965) Zihuatanejo: an experience of transpersonative living. In: Blum R (ed) Utopiates \u2013 the use and users of LSD. Tavistock Publications, London, pp 142\u2013178"},{"key":"177_CR36","first-page":"29","volume-title":"Psychedelics reimagined","author":"DP Dulchinos","year":"1999","unstructured":"Dulchinos DP (1999) Fitz Hugh Ludlow: pioneer of inner space. In: Lyttle T (ed) Psychedelics reimagined. Autonomedia, New York, pp 29\u201340"},{"key":"177_CR38","first-page":"131","volume":"73","author":"H Ellis","year":"1898","unstructured":"Ellis H (1898) Mescal, a new artificial paradise. Contemp Theatr Rev 73:131\u2013141","journal-title":"Contemp Theatr Rev"},{"key":"177_CR39","first-page":"213","volume-title":"The chemistry and pharmacology of opioids from a non-opium source","author":"E Erowid","year":"2015","unstructured":"Erowid E, Erowid F (2015) The kratom experience from firsthand reports. In: Raffa RB (ed) The chemistry and pharmacology of opioids from a non-opium source. CRC Press, Boca Raton, pp 213\u2013244"},{"key":"177_CR40","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2015) New psychoactive substances in Europe. An update from the EU early warning system. http:\/\/www.emcdda.europa.eu\/system\/files\/publications\/65\/TD0415135ENN.pdf . Accessed 1 May 2018"},{"key":"177_CR186","doi-asserted-by":"publisher","DOI":"10.1007\/164_2018_160","volume-title":"Handbook of Experimental Pharmacology","author":"Michael Evans-Brown","year":"2018","unstructured":"Evans-Brown M, Sedefov R (2018) Responding to new psychoactive substances in the European Union: early warning, risk assessment, and control measures. Handb Exp Pharmacol. https:\/\/doi.org\/10.1007\/164_2018_160"},{"key":"177_CR41","volume-title":"Angel dust. An ethnographic study of phencyclidine users","year":"1979","unstructured":"Feldman HW, Agar MH, Beschner GM (eds) (1979) Angel dust. An ethnographic study of phencyclidine users. Lexington Books, Lexington"},{"key":"177_CR42","first-page":"414","volume":"50","author":"S Ferkel","year":"1954","unstructured":"Ferkel S (1954) \u201cHexensalben\u201d und ihre Wirkung. Kosmos 50:414\u2013415","journal-title":"Kosmos"},{"key":"177_CR43","first-page":"308","volume":"5","author":"R Fischer","year":"1946","unstructured":"Fischer R (1946) Selbstbeobachtungen im Meskalinrausch. Schweiz Z Psychol 5:308\u2013313","journal-title":"Schweiz Z Psychol"},{"key":"177_CR44","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/BF02885226","volume":"111","author":"F Fr\u00e4nkel","year":"1927","unstructured":"Fr\u00e4nkel F, Jo\u00ebl E (1927) Beitr\u00e4ge zu einer experimentellen Psychopathologie: der Haschischrausch. Z ges Neurol Psychiatr 111:84\u2013106","journal-title":"Z ges Neurol Psychiatr"},{"key":"177_CR45","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/00005053-195503000-00010","volume":"121","author":"W Frederking","year":"1955","unstructured":"Frederking W (1955) Intoxicant drugs (mescaline and lysergic acid diethylamide) in psychotherapy. J Nerv Ment Dis 121:262\u2013266","journal-title":"J Nerv Ment Dis"},{"key":"177_CR46","first-page":"289","volume":"2","author":"S Freud","year":"1884","unstructured":"Freud S (1884) \u00dcber Coca. Centralbl ges Ther 2:289\u2013314","journal-title":"Centralbl ges Ther"},{"key":"177_CR47","first-page":"129","volume":"5","author":"S Freud","year":"1885","unstructured":"Freud S (1885a) Beitrag zur Kenntnis der Coca-Wirkung. Wien Med Wochenschr 5:129\u2013133","journal-title":"Wien Med Wochenschr"},{"key":"177_CR48","first-page":"253","volume":"3","author":"S Freud","year":"1885","unstructured":"Freud S (1885b) Zur Coca-Wirkung beim gesunden Menschen. Centralbl ges Ther 3:253\u2013254","journal-title":"Centralbl ges Ther"},{"key":"177_CR49","unstructured":"Friedrichs H ([1940] 2009) Die Psychologie des Meskalinrausches. VWB, Berlin"},{"key":"177_CR50","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/NMD.0000000000000113","volume":"202","author":"P Gasser","year":"2014","unstructured":"Gasser P, Holstein D, Michel Y, Doblin R, Yazar-Klosinski B, Passie T, Brenneisen R (2014) Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases. J Nerv Ment Dis 202:513\u2013520","journal-title":"J Nerv Ment Dis"},{"key":"177_CR51","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.drugalcdep.2006.04.001","volume":"85","author":"D Gonzalez","year":"2006","unstructured":"Gonzalez D, Riba J, Bouso JC, Gomez-Jarabo G, Barbanoj MJ (2006) Pattern of use and subjective effects of Salvia divinorum among recreational users. Drug Alcohol Depend 85:157\u2013162","journal-title":"Drug Alcohol Depend"},{"key":"177_CR52","first-page":"173","volume":"3","author":"S Grof","year":"1964","unstructured":"Grof S (1964) K problematice optick\u00fdch poruch v autoexperimentech s halucinogeny. \u010cesk Psychiatr 3:173\u2013181","journal-title":"\u010cesk Psychiatr"},{"key":"177_CR53","volume-title":"LSD psychotherapy","author":"S Grof","year":"1980","unstructured":"Grof S (1980) LSD psychotherapy. Hunter House, Pomona"},{"key":"177_CR54","first-page":"816","volume":"58","author":"Guttmann","year":"1921","unstructured":"Guttmann (1921) Hallluzinationen und andere Folgeerscheinungen nach experimenteller Vergiftung mit Anhalonium (Mescal). Berl Klin Wochenschr 58:816\u2013817","journal-title":"Berl Klin Wochenschr"},{"key":"177_CR55","doi-asserted-by":"crossref","DOI":"10.1037\/14025-000","volume-title":"Respiration","author":"JS Haldane","year":"1922","unstructured":"Haldane JS (1922) Respiration. Yale University Press, New Haven"},{"key":"177_CR56","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/path.1700010205","volume":"1","author":"JS Haldane","year":"1893","unstructured":"Haldane JS, Smith JL (1893) The physiological effects of air ventilated by respiration. J Pathol Bacteriol 1:168\u2013186","journal-title":"J Pathol Bacteriol"},{"key":"177_CR57","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/02791072.2016.1207827","volume":"48","author":"E Hearne","year":"2016","unstructured":"Hearne E, Van Hout MC (2016) \u201cTrip-sitting\u201d in the black hole: a netnographic study of dissociation and indigenous harm reduction. J Psychoactive Drugs 48:233\u2013242","journal-title":"J Psychoactive Drugs"},{"key":"177_CR58","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF01864855","volume":"34","author":"A Heffter","year":"1894","unstructured":"Heffter A (1894) \u00dcber Pellote. Arch Exp Pathol Pharmakol 34:65\u201386","journal-title":"Arch Exp Pathol Pharmakol"},{"key":"177_CR59","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/BF01825267","volume":"40","author":"A Heffter","year":"1898","unstructured":"Heffter A (1898) \u00dcber Pellote. Zweite Mitteilung. Arch Exp Pathol Pharmakol 40:385\u2013429","journal-title":"Arch Exp Pathol Pharmakol"},{"key":"177_CR60","volume-title":"Die Scopolaminwirkung","author":"H Heimann","year":"1952","unstructured":"Heimann H (1952) Die Scopolaminwirkung. Karger, Basel"},{"key":"177_CR61","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1520\/JFS11976J","volume":"33","author":"GL Henderson","year":"1988","unstructured":"Henderson GL (1988) Designer drugs: past history and future prospects. J Forensic Sci 33:569\u2013575","journal-title":"J Forensic Sci"},{"key":"177_CR62","volume-title":"LSD: still with us after all these years","year":"1994","unstructured":"Henderson L, Glass W (eds) (1994) LSD: still with us after all these years. Lexington Books, New York"},{"key":"177_CR63","volume-title":"The hallucinogens","author":"A Hoffer","year":"1967","unstructured":"Hoffer A, Osmond H (1967) The hallucinogens. Academic Press, New York"},{"key":"177_CR64","first-page":"117","volume":"2","author":"A Hofmann","year":"1955","unstructured":"Hofmann A (1955) The history of LSD-25. Triangle 2:117\u2013124","journal-title":"Triangle"},{"key":"177_CR65","volume-title":"LSD-mein Sorgenkind","author":"Hofmann","year":"1979","unstructured":"Hofmann (1979) LSD-mein Sorgenkind. Klett-Cotta, Stuttgart"},{"key":"177_CR66","volume-title":"The man who turned on the world","author":"M Hollingshead","year":"1973","unstructured":"Hollingshead M (1973) The man who turned on the world. Blond & Briggs, London"},{"key":"177_CR67","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/dta.2203","volume":"10","author":"LM Huppertz","year":"2018","unstructured":"Huppertz LM, Moosmann B, Auw\u00e4rter V (2018) Flubromazolam \u2013 basic pharmacokinetic evaluation of a highly potent designer benzodiazepine. Drug Test Anal 10:206\u2013211","journal-title":"Drug Test Anal"},{"key":"177_CR68","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/jms.3229","volume":"48","author":"M Hutter","year":"2013","unstructured":"Hutter M, Moosmann B, Kneisel S, Auw\u00e4rter V (2013) Characteristics of the designer drug and synthetic cannabinoid receptor agonist AM-2201 regarding its chemistry and metabolism. J Mass Spectrom 48:885\u2013894","journal-title":"J Mass Spectrom"},{"key":"177_CR69","volume-title":"The doors of perception","author":"A Huxley","year":"1954","unstructured":"Huxley A (1954) The doors of perception. Chatto & Windus, London"},{"key":"177_CR70","volume-title":"Moksha","author":"A Huxley","year":"1980","unstructured":"Huxley A (1980) Moksha. Chatto & Windus, London"},{"key":"177_CR71","first-page":"186","volume":"7","author":"W James","year":"1882","unstructured":"James W (1882) Subjective effects of nitrous oxide. Mind 7:186\u2013208","journal-title":"Mind"},{"key":"177_CR72","doi-asserted-by":"crossref","DOI":"10.1037\/10004-000","volume-title":"The varieties of religious experience","author":"W James","year":"1902","unstructured":"James W (1902) The varieties of religious experience. Longmans, New York"},{"key":"177_CR73","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/02791072.2000.10400244","volume":"32","author":"KL Jansen","year":"2000","unstructured":"Jansen KL (2000) A review of the nonmedical use of ketamine: use, users and consequences. J Psychoactive Drugs 32:419\u2013433","journal-title":"J Psychoactive Drugs"},{"key":"177_CR74","unstructured":"Jansen K ([2001] 2004) Ketamine: dreams and realities. MAPS, Sarasota"},{"key":"177_CR75","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/02791072.2001.10400480","volume":"33","author":"KL Jansen","year":"2001","unstructured":"Jansen KL, Darracot-Cankovic R (2001) The nonmedical use of ketamine, part two: a review of problem use and dependence. J Psychoactive Drugs 33:151\u2013158","journal-title":"J Psychoactive Drugs"},{"key":"177_CR76","volume-title":"The atmosphere of heaven","author":"M Jay","year":"2009","unstructured":"Jay M (2009) The atmosphere of heaven. Yale University Press, London"},{"key":"177_CR77","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-662-39675-9","volume-title":"Der Cocainismus. Ein Beitrag zur Geschichte und Psychopathologie der Rauschgifte","author":"E J\u00f6el","year":"1924","unstructured":"J\u00f6el E, Fr\u00e4nkel F (1924) Der Cocainismus. Ein Beitrag zur Geschichte und Psychopathologie der Rauschgifte. Springer, Berlin"},{"key":"177_CR78","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/BF01714434","volume":"5","author":"E J\u00f6el","year":"1926","unstructured":"J\u00f6el E, Fr\u00e4nkel F (1926) Der Haschisch-Rausch. Beitr\u00e4ge zu einer experimentellen Psychopathologie. Klin Wochenschr 5:1707\u20131709","journal-title":"Klin Wochenschr"},{"key":"177_CR79","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/BF01850202","volume":"8","author":"E Jo\u00ebl","year":"1929","unstructured":"Jo\u00ebl E, Fr\u00e4nkel F (1929) Beitr\u00e4ge zur experimentellen Psychopathologie. Klin Wochenschr 8:549\u2013550","journal-title":"Klin Wochenschr"},{"key":"177_CR80","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/BF01863674","volume":"129","author":"F Kant","year":"1928","unstructured":"Kant F, Kropf E (1928) \u00dcber Selbstversuche mit Haschisch. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol 129:319\u2013338","journal-title":"Naunyn Schmiedebergs Arch Exp Pathol Pharmakol"},{"key":"177_CR81","volume-title":"The little book of ketamine","author":"K Kelly","year":"1999","unstructured":"Kelly K (1999) The little book of ketamine. Ronin, Berkeley"},{"key":"177_CR82","volume-title":"Chemical warfare secrets almost forgotten","author":"J Ketchum","year":"2006","unstructured":"Ketchum J (2006) Chemical warfare secrets almost forgotten. Chembooks, Santa Rosa"},{"key":"177_CR83","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/dta.1570","volume":"6","author":"LA King","year":"2014","unstructured":"King LA (2014) New phenethylamines in Europe. Drug Test Anal 6:808\u2013818","journal-title":"Drug Test Anal"},{"key":"177_CR84","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/dta.319","volume":"3","author":"LA King","year":"2011","unstructured":"King LA, Kicman AT (2011) A brief history of \u2018new psychoactive substances\u2019. Drug Test Anal 3:401\u2013403","journal-title":"Drug Test Anal"},{"key":"177_CR85","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/dta.2099","volume":"9","author":"P Kintz","year":"2017","unstructured":"Kintz P, Richeval C, Jamey C, Ameline A, Allorge D, Gaulier JM, Raul JS (2017) Detection of the designer benzodiazepine metizolam in urine and preliminary data on its metabolism. Drug Test Anal 9:1026\u20131033","journal-title":"Drug Test Anal"},{"key":"177_CR86","volume-title":"Designer drugs","author":"MM Kirsch","year":"1986","unstructured":"Kirsch MM (1986) Designer drugs. CompCare Publications, Minneapolis"},{"key":"177_CR87","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1080\/02791072.2013.803647","volume":"45","author":"A Kjellgren","year":"2013","unstructured":"Kjellgren A, Jonsson K (2013) Methoxetamine (MXE) \u2013 a phenomenological study of experiences induced by a \u201clegal high\u201d from the internet. J Psychoactive Drugs 45:276\u2013286","journal-title":"J Psychoactive Drugs"},{"key":"177_CR88","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/02791072.2011.605699","volume":"43","author":"A Kjellgren","year":"2011","unstructured":"Kjellgren A, Soussan C (2011) Heaven and hell \u2013 a phenomenological study of recreational use of 4-HO-MET in Sweden. J Psychoactive Drugs 43:211\u2013219","journal-title":"J Psychoactive Drugs"},{"key":"177_CR89","first-page":"191","volume":"7","author":"A Kjellgren","year":"2013","unstructured":"Kjellgren A, Henningsson H, Soussan C (2013) Fascination and social togetherness-discussions about spice smoking on a Swedish internet forum. Subst Abuse 7:191\u2013198","journal-title":"Subst Abuse"},{"key":"177_CR90","first-page":"189","volume":"12","author":"O Klinke","year":"1889","unstructured":"Klinke O (1889) Hyoscin bei Geisteskranken. Z Nervenheilkd Psychopathol 12:189\u2013196","journal-title":"Z Nervenheilkd Psychopathol"},{"key":"177_CR91","volume-title":"Mescal and mechanisms of hallucinations","author":"H Kl\u00fcver","year":"1966","unstructured":"Kl\u00fcver H (1966) Mescal and mechanisms of hallucinations. University of Chicago Press, Chicago"},{"key":"177_CR92","first-page":"VII","volume-title":"The botany and chemistry of hallucinogens","author":"H Kl\u00fcver","year":"1980","unstructured":"Kl\u00fcver H (1980) Foreword. In: Schultes RE, Hofmann A (eds) The botany and chemistry of hallucinogens, 2nd edn. C.C. Thomas, Springflied, pp VII\u2013VVX","edition":"2"},{"key":"177_CR93","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00005053-191307000-00001","volume":"40","author":"A Knauer","year":"1913","unstructured":"Knauer A, Maloney WJ (1913) A preliminary note on the psychic action of mescaline, with special reference to the mechanism of visual hallucinations. J Nerv Ment Dis 40:425\u2013436","journal-title":"J Nerv Ment Dis"},{"key":"177_CR94","first-page":"529","volume":"11","author":"E Konrad","year":"1888","unstructured":"Konrad E (1888) Zur physiologischen und therapeutischen Wirkung des Hyoscinum hydrochloricum. Centralbl Nervenheilk 11:529","journal-title":"Centralbl Nervenheilk"},{"key":"177_CR95","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.3233\/JPD-179006","volume":"7","author":"JW Langston","year":"2017","unstructured":"Langston JW (2017) The MPTP story. J Parkinsons Dis 7:S11\u2013S22","journal-title":"J Parkinsons Dis"},{"key":"177_CR96","first-page":"83","volume":"8","author":"T Leary","year":"1966","unstructured":"Leary T (1966) Programmed communication during experiences with DMT (dimethyltryptamine). Psychedelic Rev 8:83\u201395","journal-title":"Psychedelic Rev"},{"key":"177_CR97","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00005053-196312000-00007","volume":"137","author":"T Leary","year":"1963","unstructured":"Leary T, Litwin GH, Metzner R (1963) Reactions to psilocybin administered in a supportive environment. J Nerv Ment Dis 137:561\u2013573","journal-title":"J Nerv Ment Dis"},{"key":"177_CR187","volume-title":"Phantastica. Die bet\u00e4ubenden und erregenden Genussmittel. F\u00fcr \u00c4rzte und Nicht\u00e4rzte","author":"L Lewin","year":"1924","unstructured":"Lewin L (1924) Phantastica. Die bet\u00e4ubenden und erregenden Genussmittel. F\u00fcr \u00c4rzte und Nicht\u00e4rzte. Verlag von Georg Stilke, Berlin"},{"key":"177_CR99","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/BF01923627","volume":"24","author":"L Lewin","year":"1888","unstructured":"Lewin L (1888) \u00dcber Anhalonium lewinii. Arch Exp Pathol Pharmakol 24:401\u2013411","journal-title":"Arch Exp Pathol Pharmakol"},{"key":"177_CR100","volume-title":"Phantastica: a classic survey on the use and abuse of mind-altering plants","author":"L Lewin","year":"1998","unstructured":"Lewin L (1998) Phantastica: a classic survey on the use and abuse of mind-altering plants. Park Street Press, Rochester"},{"key":"177_CR101","volume-title":"Programming and metaprogramming in the human biocomputer","author":"JC Lilly","year":"1972","unstructured":"Lilly JC (1972a) Programming and metaprogramming in the human biocomputer. Julian Press, New York"},{"key":"177_CR102","volume-title":"The center of the cyclone","author":"JC Lilly","year":"1972","unstructured":"Lilly JC (1972b) The center of the cyclone. Julian Press, New York"},{"key":"177_CR103","volume-title":"The scientist","author":"JC Lilly","year":"1978","unstructured":"Lilly JC (1978) The scientist. Crown Publishers, New York"},{"key":"177_CR104","volume-title":"The Hasheesh eater","author":"F Ludlow","year":"1857","unstructured":"Ludlow F (1857) The Hasheesh eater. Harper & Bros, New York"},{"key":"177_CR105","unstructured":"Mantegazza P (1859 [1973]) Sulle virtu igienische e medicale de la coca. Ann univers di medic Bd. 167:449ff. Partially reprinted. In: Andrews G, Solomon D (eds) The coca leaf and cocaine papers. Harcourt Brace Jovanovich, New York, pp 38\u201342"},{"key":"177_CR106","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyv065","volume":"18","author":"AE Maqueda","year":"2015","unstructured":"Maqueda AE, Valle M, Addy PH, Antonijoan RM, Puntes M, Coimbra J, Ballester MR, Garrido M, Gonzalez M, Claramunt J, Barker S, Johnson MW, Griffiths RR, Riba J (2015) Salvinorin-A induces intense dissociative effects, blocking external sensory perception and modulating interoception and sense of body ownership in humans. Int J Neuropsychopharmacol 18:pyv065","journal-title":"Int J Neuropsychopharmacol"},{"key":"177_CR107","unstructured":"Matussek N (1952) Wahnsymptome im Meskalinrausch. Medical dissertation, Max-Planck-Institut f\u00fcr Psychiatrie, M\u00fcnchen"},{"key":"177_CR108","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/168827b0","volume":"168","author":"W Mayer-Gross","year":"1951","unstructured":"Mayer-Gross W, McAdam W, Walker JW (1951) Psychological and biochemical effects of lysergic acid diethylamide. Nature 168:827\u2013828","journal-title":"Nature"},{"key":"177_CR109","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1001\/archpsyc.1967.01730290009002","volume":"17","author":"W McGlothlin","year":"1967","unstructured":"McGlothlin W, Cohen S, McGlothlin MS (1967) Long lasting effects of LSD on normals. Arch Gen Psychiatry 17:521\u2013532","journal-title":"Arch Gen Psychiatry"},{"key":"177_CR110","volume-title":"The archaic revival. Speculations on psychedelic mushrooms, the amazon, virtual reality, UFOs, evolution, shamanism, the rebirth of the goddess, and the end of history","author":"T McKenna","year":"1991","unstructured":"McKenna T (1991) The archaic revival. Speculations on psychedelic mushrooms, the amazon, virtual reality, UFOs, evolution, shamanism, the rebirth of the goddess, and the end of history. Harper Collins, San Francisco"},{"key":"177_CR111","first-page":"29","volume":"6","author":"P Meyer","year":"1993","unstructured":"Meyer P (1993) Apparent communication with discarnate entities related to DMT. Psychedelic Monogr Essays 6:29\u201367","journal-title":"Psychedelic Monogr Essays"},{"key":"177_CR112","doi-asserted-by":"publisher","unstructured":"Meyer MR (2018) Toxicokinetics of NPS: update 2017. Handb Exp Pharmacol. https:\/\/doi.org\/10.1007\/1164_2018_1102","DOI":"10.1007\/1164_2018_1102"},{"key":"177_CR113","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/0269881110378371","volume":"25","author":"MC Mithoefer","year":"2011","unstructured":"Mithoefer MC, Wagner MT, Mithoefer AT, Jerome L, Doblin R (2011) The safety and efficacy of \u00b13,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. J Psychopharmacol 25:439\u2013452","journal-title":"J Psychopharmacol"},{"key":"177_CR114","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/0269881112456611","volume":"27","author":"MC Mithoefer","year":"2013","unstructured":"Mithoefer MC, Wagner MT, Mithoefer AT, Jerome L, Martin SF, Yazar-Klosinski B, Michel Y, Brewerton TD, Doblin R (2013) Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study. J Psychopharmacol 27:28\u201339","journal-title":"J Psychopharmacol"},{"issue":"6","key":"177_CR115","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S2215-0366(18)30135-4","volume":"5","author":"Michael C Mithoefer","year":"2018","unstructured":"Mithoefer MC, Mithoefer AT, Feduccia AA, Jerome L, Wagner M, Wymer J, Holland J, Hamilton S, Yazar-Klosinski B, Emerson A, Doblin R (2018) 3,4-Methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. Lancet Psychiatry 5:486\u2013497","journal-title":"The Lancet Psychiatry"},{"key":"177_CR116","volume-title":"Journeys into the bright world","author":"M Moore","year":"1978","unstructured":"Moore M, Alltounian HS (1978) Journeys into the bright world. Para Research, Rockport"},{"key":"177_CR117","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/jms.3279","volume":"48","author":"B Moosmann","year":"2013","unstructured":"Moosmann B, Huppertz Laura M, Hutter M, Buchwald A, Ferlaino S, Auw\u00e4rter V (2013a) Detection and identification of the designer benzodiazepine flubromazepam and preliminary data on its metabolism and pharmacokinetics. J Mass Spectrom 48:1150\u20131159","journal-title":"J Mass Spectrom"},{"key":"177_CR118","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s11419-013-0187-4","volume":"31","author":"B Moosmann","year":"2013","unstructured":"Moosmann B, Hutter M, Huppertz LM, Ferlaino S, Redlingsh\u00f6fer L, Auw\u00e4rter V (2013b) Characterization of the designer benzodiazepine pyrazolam and its detectability in human serum and urine. Forensic Toxicol 31:263\u2013271","journal-title":"Forensic Toxicol"},{"key":"177_CR119","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/dta.1628","volume":"6","author":"B Moosmann","year":"2014","unstructured":"Moosmann B, Bisel P, Auw\u00e4rter V (2014) Characterization of the designer benzodiazepine diclazepam and preliminary data on its metabolism and pharmacokinetics. Drug Test Anal 6:757\u2013763","journal-title":"Drug Test Anal"},{"key":"177_CR120","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/dta.1620","volume":"6","author":"H Morris","year":"2014","unstructured":"Morris H, Wallach J (2014) From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs. Drug Test Anal 6:614\u2013632","journal-title":"Drug Test Anal"},{"key":"177_CR121","volume-title":"Lecture on Soteria treatment for psychotic patients","author":"L Mosher","year":"1999","unstructured":"Mosher L (1999) Lecture on Soteria treatment for psychotic patients. Hannover Medical School, Hannover"},{"key":"177_CR122","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/pr.115.011478","volume":"68","author":"DE Nichols","year":"2016","unstructured":"Nichols DE (2016) Psychedelics. Pharmacol Rev 68:264\u2013355","journal-title":"Pharmacol Rev"},{"key":"177_CR123","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1086\/383628","volume":"88","author":"SJ Novak","year":"1997","unstructured":"Novak SJ (1997) LSD before Leary. Sidney Cohen\u2019s critique of 1950s psychedelic drug research. Isis 88:87\u2013110","journal-title":"Isis"},{"key":"177_CR124","first-page":"67","volume-title":"Psychedelics","author":"H Osmond","year":"1970","unstructured":"Osmond H (1970) Peyote night. In: Aaronson BS, Osmond H (eds) Psychedelics. The Hogarth Press, London, pp 67\u201386"},{"key":"177_CR125","volume-title":"Psilocybin \u2013 magic mushroom grower\u2019s guide","author":"OT Oss","year":"1976","unstructured":"Oss OT, Oeric ON (1976) Psilocybin \u2013 magic mushroom grower\u2019s guide. And\/Or Press, Berkeley"},{"key":"177_CR126","volume-title":"Ayahuasca analogues\u2013Pangean entheogens","author":"J Ott","year":"1994","unstructured":"Ott J (1994) Ayahuasca analogues\u2013Pangean entheogens. Natural Products, Washington"},{"key":"177_CR127","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/02791072.1999.10471741","volume":"31","author":"J Ott","year":"1999","unstructured":"Ott J (1999) Pharmahuasca: human pharmacology of oral DMT plus harmine. J Psychoactive Drugs 31:171\u2013177","journal-title":"J Psychoactive Drugs"},{"key":"177_CR128","volume-title":"Shamanic snuffs or entheogenic errhines","author":"J Ott","year":"2001","unstructured":"Ott J (2001a) Shamanic snuffs or entheogenic errhines. Entheobotanica, Solothurn"},{"key":"177_CR129","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/02791072.2001.10400574","volume":"33","author":"J Ott","year":"2001","unstructured":"Ott J (2001b) Pharma\u00f1opo-psychonautics: human intranasal, sublingual, intrarectal, pulmonary and oral pharmacology of bufotenine. J Psychoactive Drugs 33:273\u2013281","journal-title":"J Psychoactive Drugs"},{"key":"177_CR130","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/02791072.2001.10399925","volume":"33","author":"J Ott","year":"2001","unstructured":"Ott J (2001c) Pharmep\u00e9na-psychonautics: human intranasal, sublingual and oral pharmacology of 5-methoxy-N,N-dimethyl-tryptamine. J Psychoactive Drugs 33:403\u2013407","journal-title":"J Psychoactive Drugs"},{"key":"177_CR131","first-page":"46","volume":"7","author":"T Passie","year":"1997","unstructured":"Passie T (1997) Hanscarl Leuner: pioneer of hallucinogen research and psycholytic therapy. Multidiscipl Assoc Psychedelic Stud Bull 7:46\u201349","journal-title":"Multidiscipl Assoc Psychedelic Stud Bull"},{"key":"177_CR132","volume-title":"Protocol for a research study of psilocybin in a clinical setting","author":"T Passie","year":"2002","unstructured":"Passie T (2002) Protocol for a research study of psilocybin in a clinical setting. Hannover Medical School, Hannover"},{"key":"177_CR133","first-page":"234","volume-title":"Nazis on speed","author":"T Passie","year":"2005","unstructured":"Passie T (2005) Meskalin in Deutschland 1912\u20131945: Grundlagenforschung, Selbstversuche und Missbrauch. In: Pieper W (ed) Nazis on speed, vol 2, pp 234\u2013244"},{"key":"177_CR134","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2050324518767442","volume":"4","author":"T Passie","year":"2018","unstructured":"Passie T (2018) The early use of MDMA (\u2018Ecstasy\u2019) in psychotherapy (1977\u20131985). Drug Sci Policy Law 4:1\u201319","journal-title":"Drug Sci Policy Law"},{"key":"177_CR188","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/02791072.2015.1128580","volume":"48","author":"T Passie","year":"2016","unstructured":"Passie T, Benzenh\u00f6fer U (2016) The history of MDMA as an underground drug in the United States, 1960\u20131979. J Psychoactive Drugs 48:67\u201375","journal-title":"J Psychoactive Drugs"},{"key":"177_CR135","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/dta.2292","volume":"10","author":"T Passie","year":"2018","unstructured":"Passie T, Benzenh\u00f6fer U (2018) MDA, MDMA and other \u201cmescaline-like\u201d substances in the US military\u2019s search for a truth drug (1940s to 1960s). Drug Test Anal 10:72\u201380","journal-title":"Drug Test Anal"},{"key":"177_CR136","first-page":"229","volume":"42","author":"GW Pickering","year":"1949","unstructured":"Pickering GW (1949) The place of experimental method in medicine. Proc R Soc Med 42:229\u2013234","journal-title":"Proc R Soc Med"},{"key":"177_CR137","first-page":"577","volume":"19","author":"DW Prentiss","year":"1895","unstructured":"Prentiss DW, Morgan FP (1895) Anhalonium lewinii (Mescal buttons): a study of the drug with special reference to its physiological action upon man with report of experiments. Therapeut Gaz 19:577\u2013585","journal-title":"Therapeut Gaz"},{"key":"177_CR138","first-page":"277","volume":"8","author":"H Prinzhorn","year":"1927","unstructured":"Prinzhorn H (1927) Erdentr\u00fcckte Seele. Leuchter 8:277\u2013296","journal-title":"Leuchter"},{"key":"177_CR139","first-page":"24","volume":"55","author":"H Prinzhorn","year":"1928","unstructured":"Prinzhorn H (1928) Entr\u00fcckung durch Rauschgift. Zeitsch Parapsychol 55:24\u201334","journal-title":"Zeitsch Parapsychol"},{"key":"177_CR140","unstructured":"Resnikoff C (2018) Mail to Torsten Passie. 6 Apr 2018"},{"key":"177_CR141","first-page":"253","volume-title":"The coca leaf and cocaine papers","author":"FW Ring","year":"1887","unstructured":"Ring FW (1887) Cocaine and its fascinations, from a personal experience. Medical Record, September 3, 1887. In: Andrews G, Solomon D (eds) The coca leaf and cocaine papers, vol 1973. Harcourt Brace Jovanovich, New York, pp 253\u2013258"},{"key":"177_CR142","volume-title":"Experiment\u00e1ln\u00ed psychosy","author":"J Roub\u00ed\u010dek","year":"1961","unstructured":"Roub\u00ed\u010dek J (1961) Experiment\u00e1ln\u00ed psychosy. SZdN, Prague"},{"key":"177_CR143","unstructured":"Shedlin M, Wallechinski D, Sayler S (eds) ([1973] 1992) Laughing gas. Ronin, Berkeley"},{"key":"177_CR144","first-page":"93","volume":"1","author":"AT Shulgin","year":"1975","unstructured":"Shulgin AT (1975) Centrally active phenethylamines. Psychopharmacol Commun 1:93\u201398","journal-title":"Psychopharmacol Commun"},{"key":"177_CR145","volume-title":"PIHKAL","author":"A Shulgin","year":"1991","unstructured":"Shulgin A, Shulgin A (1991) PIHKAL. Transform Press, Berkeley"},{"key":"177_CR146","volume-title":"TIHKAL","author":"A Shulgin","year":"1997","unstructured":"Shulgin A, Shulgin A (1997) TIHKAL. Transform Press, Berkeley"},{"key":"177_CR147","first-page":"313","volume":"8","author":"AT Shulgin","year":"1986","unstructured":"Shulgin AT, Shulgin LA, Jacob PA (1986) A protocol for the evaluation of new psychoactive drugs. Methods Find Exp Clin Pharmacol 8:313\u2013320","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"177_CR148","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0378-8741(94)90116-3","volume":"43","author":"DJ Siebert","year":"1994","unstructured":"Siebert DJ (1994) Salvia divinorum and Salvinorin A \u2013 new pharmacological findings. J Ethnopharmacol 43:53\u201356","journal-title":"J Ethnopharmacol"},{"key":"177_CR149","volume-title":"The Oxford encyclopaedic English dictionary","year":"1989","unstructured":"Simpson ESC, Weiner JA (eds) (1989) The Oxford encyclopaedic English dictionary. Clarendon Press, Oxford"},{"key":"177_CR150","first-page":"429","volume":"17","author":"H Solms","year":"1956","unstructured":"Solms H (1956) Relationships between chemical structure and psychoses with the use of psychotoxic substances. \u201cComparative pharmacopsychiatric analysis\u201d: a new research method. J Clin Exp Psychopathol 17:429\u2013433","journal-title":"J Clin Exp Psychopathol"},{"key":"177_CR151","first-page":"IX","volume-title":"LSD \u2013 the consciousness-expanding drug","author":"D Solomon","year":"1964","unstructured":"Solomon D (1964) Editor\u2019s preface. In: Solomon D (ed) LSD \u2013 the consciousness-expanding drug. Putnam\u2019s, New York, pp IX\u2013IX"},{"key":"177_CR152","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1477-7517-11-25","volume":"11","author":"C Soussan","year":"2014","unstructured":"Soussan C, Kjellgren A (2014) Harm reduction and knowledge exchange \u2013 a qualitative analysis of drug-related internet discussion forums. Harm Red J 11:25\u201333","journal-title":"Harm Red J"},{"key":"177_CR153","first-page":"9","volume":"9","author":"C Soussan","year":"2015","unstructured":"Soussan C, Kjellgren A (2015) \u201cChasing the high\u201d \u2013 experiences of ethylphenidate as described on international internet forums. Subst Abuse 9:9\u201316","journal-title":"Subst Abuse"},{"key":"177_CR154","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.drugpo.2017.11.003","volume":"52","author":"C Soussan","year":"2018","unstructured":"Soussan C, Andersson M, Kjellgren A (2018) The diverse reasons for using novel psychoactive substances \u2013 a qualitative study of the users\u2019 own perspectives. Int J Drug Policy 52:71\u201378","journal-title":"Int J Drug Policy"},{"key":"177_CR155","unstructured":"Stafford P (1990) Magic grams: investigations into psychedelic consciousness with Dr. Oscar Janiger. Psychedelic Monogr Essays 5"},{"key":"177_CR156","volume-title":"Thanatos to Eros: thirty-five years of psychedelic exploration","author":"M Stolaroff","year":"1994","unstructured":"Stolaroff M (1994) Thanatos to Eros: thirty-five years of psychedelic exploration. VWB, Berlin"},{"key":"177_CR157","volume-title":"The secret chief revealed","author":"M Stolaroff","year":"2004","unstructured":"Stolaroff M (2004) The secret chief revealed. MAPS, Sarasota"},{"key":"177_CR158","first-page":"279","volume":"60","author":"WA Stoll","year":"1947","unstructured":"Stoll WA (1947) Lysergs\u00e4ure-di\u00e4thylamid, ein Phantastikum aus der Mutterkorngruppe. Schweiz Arch Neurol Psychiat 60:279\u2013280","journal-title":"Schweiz Arch Neurol Psychiat"},{"key":"177_CR159","first-page":"149","volume-title":"Welten des Bewusstseins","author":"J Styk","year":"1994","unstructured":"Styk J (1994) R\u00fcckblick auf die letzten sieben Jahre der Schweizerischen \u00c4rztegesellschaft f\u00fcr Psycholytische Therapie (S\u00c4PT). In: Dittrich A, Hofmann A, Leuner H (eds) Welten des Bewusstseins, vol 4. VWB, Berlin, pp 149\u2013154"},{"key":"177_CR160","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1080\/02791072.2015.1096434","volume":"47","author":"MT Swogger","year":"2015","unstructured":"Swogger MT, Hart E, Erowid F, Erowid E, Trabold N, Yee K, Parkhurst KA, Priddy BM, Walsh Z (2015) Experiences of Kratom users: a qualitative analysis. J Psychoactive Drugs 47:360\u2013367","journal-title":"J Psychoactive Drugs"},{"key":"177_CR161","first-page":"460","volume-title":"Psychotropic drugs","author":"S Sz\u00e1ra","year":"1957","unstructured":"Sz\u00e1ra S (1957) The comparison of the psychotic effect of tryptamine derivatives with the effects of mescaline and LSD-25 in self-experiments. In: Garattini S, Ghetti V (eds) Psychotropic drugs. Elsevier, Amsterdam, pp 460\u2013467"},{"key":"177_CR162","first-page":"885","volume":"20","author":"S Sz\u00e1ra","year":"1961","unstructured":"Sz\u00e1ra S (1961) Hallucinogenic effects and metabolism of tryptamine derivatives in man. Fed Proc 20:885\u2013888","journal-title":"Fed Proc"},{"key":"177_CR163","doi-asserted-by":"publisher","unstructured":"Tettey JNA, Crean C, Ifeagwu SC, Raithelhuber M (2018) Emergence, diversity and control of new psychoactive substances \u2013 a global perspective. Handb Exp Pharmacol. https:\/\/doi.org\/10.1007\/164_2018_XXX","DOI":"10.1007\/164_2018_XXX"},{"key":"177_CR164","volume-title":"Psychedelische chemie","author":"D Trachsel","year":"2011","unstructured":"Trachsel D (2011) Psychedelische chemie. Nachtschatten Verlag, Solothurn"},{"key":"177_CR165","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/dta.413","volume":"4","author":"D Trachsel","year":"2012","unstructured":"Trachsel D (2012) Fluorine in psychedelic phenethylamines. Drug Test Anal 4:577\u2013590","journal-title":"Drug Test Anal"},{"key":"177_CR166","volume-title":"Phenethylamine: Von der Struktur zur Funktion","author":"D Trachsel","year":"2013","unstructured":"Trachsel D, Lehmann D, Enzensperger C (2013) Phenethylamine: Von der Struktur zur Funktion. Nachtschatten Verlag, Solothurn"},{"key":"177_CR167","volume-title":"Salvinorin \u2013 the psychedelic essence of Salvia divinorum","author":"DM Turner","year":"1996","unstructured":"Turner DM (1996) Salvinorin \u2013 the psychedelic essence of Salvia divinorum. Panther Press, San Francisco"},{"key":"177_CR168","unstructured":"United Nations Office on Drugs and Crime (UNODC) (2018) Understanding the synthetic drug market: the NPS factor. https:\/\/www.unodc.org\/documents\/scientific\/Global_Smart_Update_2018_Vol.19.pdf . Accessed 29 May 2018"},{"key":"177_CR169","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0378-8741(83)90004-1","volume":"7","author":"LJ Valdes","year":"1982","unstructured":"Valdes LJ, Diaz JL, Paul AG (1982) Ethnopharmacology of Ska Maria Pastora (Salvia divinorum Epling and Jativa-M.). J Ethnopharmacol 7:287\u2013312","journal-title":"J Ethnopharmacol"},{"key":"177_CR170","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2117\/psysoc.1961.11","volume":"4","author":"W Dusen Van","year":"1961","unstructured":"Van Dusen W (1961) LSD and the enlightenment of Zen. Psychologia 4:11\u201316","journal-title":"Psychologia"},{"key":"177_CR171","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/02791072.2014.934979","volume":"46","author":"MC Hout Van","year":"2014","unstructured":"Van Hout MC (2014) An internet study of user\u2019s experiences of the synthetic cathinone 4-methylethcathinone (4-MEC). J Psychoactive Drugs 46:273\u2013286","journal-title":"J Psychoactive Drugs"},{"key":"177_CR172","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.drugpo.2015.04.002","volume":"26","author":"MC Hout Van","year":"2015","unstructured":"Van Hout MC, Hearne E (2015a) \u201cPlant or poison\u201d: a netnographic study of recreational use of 1,3-dimethylamylamine (DMAA). Int J Drug Policy 26:1279\u20131281","journal-title":"Int J Drug Policy"},{"key":"177_CR173","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/02791072.2014.974002","volume":"47","author":"MC Hout Van","year":"2015","unstructured":"Van Hout MC, Hearne E (2015b) \u201cWord of mouse\u201d: indigenous harm reduction and online consumerism of the synthetic compound methoxphenidine. J Psychoactive Drugs 47:30\u201341","journal-title":"J Psychoactive Drugs"},{"key":"177_CR174","doi-asserted-by":"publisher","unstructured":"Wagmann L, Maurer HH (2018) Bioanalytical methods for new psychoactive substances. Handb Exp Pharmacol. https:\/\/doi.org\/10.1007\/1164_2017_1083","DOI":"10.1007\/1164_2017_1083"},{"key":"177_CR175","volume-title":"Psychiatrie, psychopharmaka und drogen in Z\u00fcrich","author":"PG Waser","year":"1990","unstructured":"Waser PG (1990) Psychiatrie, psychopharmaka und drogen in Z\u00fcrich. Kommissionsverlag Beer AG, Z\u00fcrich"},{"key":"177_CR176","doi-asserted-by":"crossref","first-page":"77","DOI":"10.5962\/p.168538","volume":"20","author":"RG Wasson","year":"1962","unstructured":"Wasson RG (1962) Salvia divinorum \u2013 a new psychotropic drug from the mint family. Bot Mus Leafl Harvard Univ 20:77\u201384","journal-title":"Bot Mus Leafl Harvard Univ"},{"key":"177_CR177","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/02791072.1976.10471861","volume":"8","author":"A Weil","year":"1976","unstructured":"Weil A (1976) MDA \u2013 the love drug. J Psychedelic Drugs 8:335\u2013337","journal-title":"J Psychedelic Drugs"},{"key":"177_CR178","volume-title":"The marriage of the sun and the moon","author":"A Weil","year":"1980","unstructured":"Weil A (1980) The marriage of the sun and the moon. Houghton Mifflin, Boston"},{"key":"177_CR179","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1136\/bmj.2.1875.1625","volume":"2","author":"S Weir Mitchell","year":"1896","unstructured":"Weir Mitchell S (1896) Remarks on the effects of Anhelonium lewinii (the mescal button). Br Med J 2:1625\u20131629","journal-title":"Br Med J"},{"key":"177_CR180","unstructured":"Wellen BJ (1986) Zur Geschichte des Bilsenkrautes. Dissertation, Fachbereich Pharmazie Philipps-Universit\u00e4t Marburg, Marburg"},{"key":"177_CR181","unstructured":"Weyl B (1951) Versuch einer psychopathologischen analyse der LSD-Wirkung. Medical dissertation, Albert-Ludwig-University Freiburg, Freiburg im Breisgau"},{"key":"177_CR182","volume-title":"Ins Herz der Dinge Lauschen","author":"S Widmer","year":"1997","unstructured":"Widmer S (1997) Ins Herz der Dinge Lauschen, 2nd edn. Nachtschatten, Solothurn","edition":"2"},{"key":"177_CR183","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/02791072.2013.873158","volume":"46","author":"P Winkler","year":"2014","unstructured":"Winkler P, Cs\u00e9my L (2014) Self-experimentations with psychedelics among mental health professionals: LSD in the former Czechoslovakia. J Psychoactive Drugs 46:11\u201319","journal-title":"J Psychoactive Drugs"},{"key":"177_CR184","first-page":"226","volume":"11","author":"HC Wood Jr","year":"1869","unstructured":"Wood HC Jr (1869) On the medical activity of the hemp plant as grown in North America. Proc Am Philos Soc 11:226\u2013232","journal-title":"Proc Am Philos Soc"},{"key":"177_CR185","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/BF01710217","volume":"5","author":"K Zucker","year":"1926","unstructured":"Zucker K (1926) Die pharmakologische Betrachtungsweise als Forschungsmethode in der Neurologie und Psychiatrie. Klin Wochenschr 5:1977\u20131779","journal-title":"Klin Wochenschr"}],"container-title":["Handbook of Experimental Pharmacology","New Psychoactive Substances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/164_2018_177","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T19:22:29Z","timestamp":1720812149000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/164_2018_177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9783030105600","9783030105617"],"references-count":186,"URL":"https:\/\/doi.org\/10.1007\/164_2018_177","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]},"assertion":[{"value":"27 November 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}